{
    "nct_id": "NCT03565367",
    "official_title": "A Pilot Study to Assess Lactate and Bicarbonate Detection Within Malignant Brain Tumors Using [1-13C]-Pyruvate DNP Magnetic Resonance Spectroscopy (MRS)",
    "inclusion_criteria": "* Patients with a known diagnosis of central nervous system (CNS) malignancy, including metastases, with known enhancement on magnetic resonance (MR) who are otherwise eligible to undergo MRI\n* Glomerular filtration rate (GFR) > 30 ml/min\n* No allergy to gadolinium\n* Ability to understand and the willingness to sign a written informed consent document\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Refusal to have an IV placed for injection\n* Acute major illness (e.g., unstable angina, etc.) or other condition that makes participation unsafe, per the investigator?s judgement\n* Total bilirubin > 1.5 x upper limit of normal (ULN)\n* Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) > 2.5 x ULN\n* Gamma-glutamyltransferase (GGT) > 2.5 x ULN\n* Pregnant or breast-feeding\n* Cardiovascular risk, including:\n\n  * Poorly controlled hypertension, defined as either systolic > 170 or diastolic > 110\n  * Congestive heart failure\n  * Myocardial infarction within the past year\n  * QT prolongation, defined as pretreatment corrected QT interval (QTc) > 440 msec in males or > 460 msec in females",
    "miscellaneous_criteria": ""
}